Cerebril™ in Patients With Lobar Hemorrhage Related to Cerebral Amyloid Angiopathy

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The main objective of this study is to evaluate the safety, tolerability and pharmacokinetics of Cerebril™ in Cerebral Amyloid Angiopathy (CAA) patients who have had lobar cerebral hemorrhage.
Epistemonikos ID: bd667882dfda27942a2608b5da4a3a9c890b7d6d
First added on: May 04, 2024